• Subscribe
  • Newsfeed
  • About
Announce News

University of Cambridge

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune diseaseT-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
    T-Therapeutics
    13 Nov 2025

    T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease

    T-Therapeutics develops next-generation T cell receptor therapies designed to target cancer and autoimmune disease, advancing bispecific molecules that selectively remove disease-driving immune cells while preserving healthy function.

    NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horsesNoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses
    NoBACZ
    30 Sept 2025

    NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses

    NoBACZ Healthcare develops antibiotic-free liquid bandage technology for livestock and horses, creating protective wound coatings that reduce infection risk in agricultural environments.

    Robin AI, leader in legal AI for business, confirms £20m further funding from customers and investors including Paypal VenturesRobin AI, leader in legal AI for business, confirms £20m further funding from customers and investors including Paypal Ventures
    Robin AI
    14 Nov 2024

    Robin AI, leader in legal AI for business, confirms £20m further funding from customers and investors including Paypal Ventures

    Robin AI develops legal AI software for large enterprises that analyses, summarises and extracts insights from complex contracts and documents, supporting due diligence, compliance and incident response at scale.

University of Cambridge
    • Life Sciences
    • Agriculture
    • Legal
  • 2(12 months)
  • cam.ac.uk
  • Update Information

More venture news

  • SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI
    SurrealDB
    17 Feb 2026

    SurrealDB secures a £17m Series A extension led by Chalfen Ventures and Begin Capital for its multi-model database for AI

    ExtensionEnterprise
  • T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease
    T-Therapeutics
    13 Nov 2025

    T-Therapeutics secures £24m Series A extension with Tencent and BGF to develop T cell receptor therapeutics for cancer and autoimmune disease

    ExtensionLife Sciences
  • PhysicsX secures Series B extension from NVentures to advance new software stack for AI-native engineering
    PhysicsX
    19 Nov 2025

    PhysicsX secures Series B extension from NVentures to advance new software stack for AI-native engineering

    ExtensionDeep Tech

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn